% Expired Patents = 100.0

Forward Citations = 15

Loading Chart...

10 inventors (with patents filed for the assignee):

Dieter Koegst (4 out of 6 patents)

Gerhard Fries (4 out of 6 patents)

Reinhard Neubert (3 out of 7 patents)

4. Christoph Huschka (3 out of 4 patents)

5. Wolfgang A Wohlrab (3 out of 8 patents)

6. Jörg-Herman Ozegowski (2 out of 2 patents)

7. Peter-Jürgen Müller (2 out of 2 patents)

8. Siegfried Ansorge (1 out of 10 patents)

9. Michael Taeger (1 out of 2 patents)

10. Jürgen Schneider (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 7429614 - Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus (2008-09-30),

2. 6719986 - Hyaluronate lyase used for promoting penetration in topical agents (2004-04-13),

3. 6689349 - Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis (2004-02-10),

4. 6413950 - Pharmaceutical preparation containing dithranol (2002-07-02),

Company Overview

Esparma GmbH is a pharmaceutical company based in Germany, specializing in the development and manufacturing of high-quality generic drugs. With a focus on innovation and customer satisfaction, Esparma strives to provide affordable and effective medications to improve the lives of patients worldwide. The company's product portfolio ranges from cardiovascular drugs to pain management medications, all manufactured in state-of-the-art facilities. Esparma is committed to adhering to the highest standards of quality and safety in all aspects of its operations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#420 in Osterweddigen

#7,035 in Germany

Osterweddigen, Germany

Esparma Gmbh

Forward Citations = 15

10 inventors:

Dieter Koegst (4 out of 6 patents)

Gerhard Fries (4 out of 6 patents)

Reinhard Neubert (3 out of 7 patents)

4. Christoph Huschka (3 out of 4 patents)

5. Wolfgang A Wohlrab (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Esparma Gmbh. Retrieved from https://idiyas.com/company/esparma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]